ELAN
Elanco Animal Health
NYSE: ELAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$21.80
-1.58% today
Updated 2026-04-29
Market cap
$10.89B
P/E ratio
—
P/S ratio
2.31x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$9 – $28
Volume
5.1M
Elanco Animal Health (ELAN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.91B | $2.91B | $2.89B | $3.07B | $3.07B | $3.27B | $4.76B | $4.41B | $4.42B | $4.44B | $4.71B |
| Revenue growth (YoY) | — | +0.2% | -0.8% | +6.2% | +0.1% | +6.6% | +45.5% | -7.4% | +0.1% | +0.5% | +6.2% |
| Cost of revenue | $1.70B | $1.58B | $1.72B | $1.77B | $1.67B | $2.03B | $2.69B | $2.44B | $2.48B | $2.53B | $2.67B |
| Gross profit | $1.21B | $1.33B | $1.17B | $1.30B | $1.40B | $1.25B | $2.08B | $1.97B | $1.94B | $1.91B | $2.05B |
| Gross margin | 41.7% | 45.8% | 40.6% | 42.2% | 45.6% | 38.1% | 43.6% | 44.7% | 43.9% | 43.0% | 43.5% |
| R&D | $291.00M | $265.80M | $251.70M | $246.60M | $270.10M | $327.00M | $369.00M | $321.00M | $327.00M | $344.00M | $368.00M |
| SG&A | $916.00M | $784.80M | $779.80M | $735.20M | $760.20M | $996.60M | $1.16B | $1.06B | $1.07B | $1.07B | $1.43B |
| Operating income | $5.40M | $283.20M | $142.40M | $313.80M | $370.00M | $-76.80M | $304.00M | $384.00M | $326.00M | $251.00M | $252.00M |
| Operating margin | 0.2% | 9.7% | 4.9% | 10.2% | 12.0% | -2.3% | 6.4% | 8.7% | 7.4% | 5.7% | 5.3% |
| EBITDA | $-22.60M | $232.00M | $85.80M | $439.70M | $471.60M | $900000.00 | $409.00M | $866.00M | $-224.00M | $1.49B | $676.00M |
| EBITDA margin | -0.8% | 8.0% | 3.0% | 14.3% | 15.4% | 0.0% | 8.6% | 19.6% | -5.1% | 33.5% | 14.3% |
| EBIT | $-259.50M | $-22.40M | $-232.60M | $143.70M | $157.10M | $-516.00M | $-307.00M | $184.00M | $-918.00M | $827.00M | $-4.00M |
| Interest expense | $0.00 | $0.00 | $0.00 | $29.60M | $78.90M | $156.00M | $264.00M | $256.00M | $277.00M | $339.00M | $220.00M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-210.80M | $-47.90M | $-310.70M | $86.50M | $67.90M | $-560.10M | $-483.00M | $-78.00M | $-1.23B | $338.00M | $-232.00M |
| Net income growth (YoY) | — | +77.3% | -548.6% | +127.8% | -21.5% | -924.9% | +13.8% | +83.9% | -1478.2% | +127.5% | -168.6% |
| Profit margin | -7.2% | -1.6% | -10.8% | 2.8% | 2.2% | -17.1% | -10.1% | -1.8% | -27.9% | 7.6% | -4.9% |